DuP-129

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDuP-129
Drug Alias NameACAT inhibitors (Du Pont)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase inhibitors
TargetsAcyl coenzyme A:cholesterol acyltransferase
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Pharma Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Pharma Company
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A